The Gore Cardioform Atrial Septal Defect Occluder: A novel solution to the management of severe hemolysis following transcatheter septal defect closure

Iman Naimi; Thomas K Jones; Zachary Steinberg

doi:10.1002/ccd.30144

The Gore Cardioform Atrial Septal Defect Occluder: A novel solution to the management of severe hemolysis following transcatheter septal defect closure

Catheter Cardiovasc Interv. 2022 Apr;99(5):1679-1682. doi: 10.1002/ccd.30144. Epub 2022 Mar 7.

Authors

Iman Naimi^{1

2}, Thomas K Jones^{2

3}, Zachary Steinberg³

Affiliations

¹ Department of Pediatric Cardiology, Stollery Children's Hospital, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
² Department of Pediatric Cardiology, Seattle Children's Hospital, University of Washington School of Medicine, Seattle, Washington, USA.
³ Department of Cardiology, University of Washington Medical Center, University of Washington School of Medicine, Seattle, Washington, USA.

PMID: 35253339
DOI: 10.1002/ccd.30144

Abstract

Significant hemolysis is a recognized complication of transcatheter high-velocity shunt occlusion using some Amplatzer devices. We describe a case of severe hemolysis following occlusion of an iatrogenic Gerbode defect with an Amplatzer muscular ventricular septal defect occluder successfully managed by transcatheter device removal and reocclusion with a Gore Cardioform Atrial Septal Defect Occluder.

Keywords: Gerbode-type VSD; aortic valve replacement; right heart catheterization; structural heart disease intervention.

Publication types

Case Reports

MeSH terms

Cardiac Catheterization / adverse effects
Heart Septal Defects, Atrial* / complications
Heart Septal Defects, Atrial* / diagnostic imaging
Heart Septal Defects, Atrial* / therapy
Heart Septal Defects, Ventricular*
Hemolysis
Humans
Septal Occluder Device* / adverse effects
Treatment Outcome